Automated Accounts Payable provider Glantus Holdings raises 14M and successfully floats on AIM. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.50
Bid: 125.00
Ask: 130.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.00%)
Open: 127.50
High: 127.50
Low: 127.50
Yest. Close: 127.50
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

Wed, 12th Aug 2020 13:35

ReNeuron Group PLC - Bridgend, Wales-based cell-based therapeutics - Appoints Mark Evans, chair of 16% shareholder Obotritia Capital KGaA, as non-executive director. Says ReNeuron and Obotritia sign relationship agreement to ensure independence of ReNeuron. Evans doesn't control the investment decisions of Obotritia, but separately from Obotritia has a 0.1% direct interest in ReNeuron and 1.7% via investment firms Partners Investment Co LLP and Albermarle Life Sciences LLP. ReNeuron promotes Non-Executive Director Tim Corn to be new chair, as John Berriman, Simon Cartmell and Claudia D'Augusta all step down. ReNeuron had said late last month it intended to reduce the number of non-executive directors on its board to four from six.

Current stock price: 111.00 pence

Year-to-date change: down 25%

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

ReNeuron signs new collaboration agreements

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced the signing of new collaboration agreements with a major pharmaceutical company and leading academic institutions in the UK and mainland Europe on Friday.

19 Mar 21 16:43

ReNeuron inks commercial collaboration deals for exosome platform

ReNeuron inks commercial collaboration deals for exosome platform

19 Mar 21 11:34

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

19 Mar 21 11:20

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

12 Mar 21 15:39

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

27 Jan 21 13:43

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

15 Jan 21 15:29

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

17 Dec 20 22:00

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

11 Dec 20 14:26

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

24 Nov 20 14:41

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

23 Nov 20 19:09

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

10 Sep 20 16:01

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

3 Sep 20 16:06

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

12 Aug 20 13:35

ReNeuron gets patent allowance in the US

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Friday that the US Patent and Trademark office (USPTO) has completed its examination of its application titled 'phenotype profile of human retinal progenitor cells', and has issued a notification of allowance for the issue of a patent.

31 Jul 20 16:22

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

31 Jul 20 11:28

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.